The manufacturing process should remain the focus for severe febrile reactions in children administered an A ustralian inactivated influenza vaccine during 2010-Reference-Cited by-同舟云学术

The manufacturing process should remain the focus for severe febrile reactions in children administered an A ustralian inactivated influenza vaccine during 2010

Published:2015-12-11 Issue:1 Volume:10 Page:9-13
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Other Respi Viruses

Author:

Li‐Kim‐Moy Jean¹²,Booy Robert¹²³⁴

Affiliation:

1. National Centre for Immunisation Research and Surveillance The Children's Hospital at Westmead Sydney NSW Australia

2. Sydney Medical School The University of Sydney Sydney NSW Australia

3. The Children's Hospital at Westmead Sydney NSW Australia

4. Marie Bashir Institute for Infectious Diseases & Biosecurity University of Sydney Sydney NSW Australia

Funder

Roche

Abbott Fund

Sanofi

GlaxoSmithKline

Novartis

Pfizer

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/irv.12337

Reference25 articles.

1. Oculo‐respiratory Syndrome: A New Influenza Vaccine–Associated Adverse Event?

2. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis

3. Evaluation of the bioactivity of influenza vaccine strains in vitro suggests that the introduction of new strains in the 2010 Southern Hemisphere Trivalent Influenza Vaccine is associated with adverse events

4. Therapeutic Goods Administration.Overview of vaccine regulation and safety monitoring and investigation into adverse events following 2010 seasonal influenza vaccination in young children.2010. Available athttps://www.tga.gov.au/file/555/download(Accessed 11 September 2012).

5. Centers for Disease Control and Prevention.ACIP recommendation for use of CSL influenza vaccine.2010. Available athttp://www.cdc.gov/media/pressrel/2010/s100806.htm(Accessed 16 February 2015).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder;Journal of Neurology, Neurosurgery & Psychiatry;2021-08-06

2. Defining Causality in Neurological & Neuropsychiatric COVID-19 Vaccine Complications: What Have We Learnt from Current and Previous Vaccination Campaigns?;SSRN Electronic Journal;2021

3. Biopharmaceutical molecules;New and Future Developments in Microbial Biotechnology and Bioengineering;2020

4. Modern Production Strategies in the Vaccine Industry;Biopharmaceutical Processing;2018

5. Variations or Changes to an Approved Application;Fundamentals of Biologicals Regulation;2018